HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kleopatra H Schulpis Selected Research

Ca(2+) Mg(2+)-ATPase

3/2005Mg2+-ATPase activity in suckling rat brain regions in galactosaemia in vitro. L-Cysteine and glutathione effects.
3/2005The protective effect of L-cysteine and glutathione on the adult and aged rat brain (Na+,K+)-ATPase and Mg2+-ATPase activities in galactosemia in vitro.
5/2004Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+, K+, -ATPase and Mg2+ -ATPase activities induced by the in vitro galactosaemia.
11/2002The in vitro effects of galactose and its derivatives on rat brain Mg2+-ATPase activity.
6/2002In vivo effects of high phenylalanine blood levels on Na+,K+-ATPase, Mg2+-ATPase activities and biogenic amine concentrations in phenylketonuria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kleopatra H Schulpis Research Topics

Disease

10Phenylketonurias (Phenylketonuria)
08/2020 - 06/2002
9Galactosemias (Galactosemia)
01/2014 - 09/2002
4Birth Weight (Birth Weights)
12/2020 - 08/2019
2Overweight
01/2020 - 05/2015
2Obesity
05/2015 - 08/2004
2Chronic Hepatitis B
03/2008 - 03/2008
2Coronary Disease (Coronary Heart Disease)
06/2006 - 06/2004
2Intellectual Disability (Idiocy)
03/2006 - 09/2005
2Seizures (Absence Seizure)
03/2006 - 09/2005
2Jaundice (Icterus)
07/2004 - 05/2003
1Cystic Fibrosis (Mucoviscidosis)
01/2021
1Parkinsonian Disorders (Parkinsonism)
03/2020
1Pseudobulbar Palsy
03/2020
1Paralysis (Palsy)
03/2020
1Metabolic Diseases (Metabolic Disease)
01/2020
1Diabetes Mellitus
01/2020
1Maternal Phenylketonuria
01/2020
1Gestational Diabetes (Gestational Diabetes Mellitus)
01/2020
1Type 2 Diabetes Mellitus (MODY)
05/2015
1Glucosephosphate Dehydrogenase Deficiency
04/2014
1Liver Diseases (Liver Disease)
01/2009
1Infections
03/2008
1Virus Diseases (Viral Diseases)
03/2008
1Homocystinuria
03/2006
1Cardiovascular Diseases (Cardiovascular Disease)
03/2006
1Atherosclerosis
10/2005
1Inflammation (Inflammations)
10/2005
1Edema (Dropsy)
03/2005
1Acne Vulgaris
01/2005
1Insulin Resistance
08/2004
1Neonatal Jaundice
05/2003

Drug/Important Bio-Agent (IBA)

10Phenylalanine (L-Phenylalanine)FDA Link
11/2020 - 06/2002
7Galactose (Galactopyranose)FDA LinkGeneric
01/2014 - 11/2002
5EnzymesIBA
01/2009 - 09/2002
5Ca(2+) Mg(2+)-ATPaseIBA
03/2005 - 06/2002
4galactose-1-phosphateIBA
09/2005 - 11/2002
4GalactitolIBA
03/2005 - 11/2002
4Adenosine Triphosphatases (ATPase)IBA
03/2005 - 06/2002
3Glutamine (L-Glutamine)FDA Link
11/2020 - 07/2011
3Amino AcidsFDA Link
11/2020 - 08/2019
3Arginine (L-Arginine)FDA Link
11/2020 - 07/2011
3Tyrosine (L-Tyrosine)FDA Link
11/2020 - 08/2004
3AcetylcholinesteraseIBA
03/2006 - 10/2002
31-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
09/2005 - 03/2005
3AntioxidantsIBA
03/2005 - 05/2004
2Carnitine (L-Carnitine)FDA LinkGeneric
01/2021 - 12/2020
2OrnithineIBA
11/2020 - 07/2011
2Methionine (L-Methionine)FDA Link
11/2020 - 03/2006
2CitrullineIBA
11/2020 - 07/2011
2Racemases and Epimerases (Epimerases and Racemases)IBA
01/2014 - 11/2007
2Free RadicalsIBA
01/2009 - 05/2004
2BiotinidaseIBA
03/2008 - 05/2003
2oxidized low density lipoproteinIBA
06/2006 - 06/2004
2HomocysteineIBA
03/2006 - 10/2005
2Hormones (Hormone)IBA
10/2005 - 08/2004
2CatecholaminesIBA
10/2005 - 08/2004
2P-2 (P 2)IBA
09/2005 - 03/2005
2CopperIBA
07/2004 - 06/2004
2Biogenic Amines (Biogenic Amine)IBA
10/2002 - 06/2002
1acylcarnitineIBA
12/2020
1Leucine (L-Leucine)FDA Link
11/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2020
1Alanine (L-Alanine)FDA Link
11/2020
1Essential Amino AcidsIBA
11/2020
1Valine (L-Valine)FDA Link
11/2020
1Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA
08/2020
1Glutamic Acid (Glutamate)FDA Link
03/2020
1Levodopa (L Dopa)FDA LinkGeneric
03/2020
1CarbohydratesIBA
01/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
05/2015
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
04/2014
1Proteins (Proteins, Gene)FDA Link
07/2011
1Pharmaceutical PreparationsIBA
01/2009
1arylesteraseIBA
03/2008
1Aryldialkylphosphatase (Paraoxonase)IBA
03/2008
1Valproic Acid (Depakote)FDA LinkGeneric
06/2006
1MetalsIBA
06/2006
1LipidsIBA
06/2006
1HomocystineIBA
03/2006
1AdiponectinIBA
10/2005
1Phosphates (Orthophosphate)IBA
03/2005
1Glutathione (Reduced Glutathione)IBA
03/2005
1Cysteine (L-Cysteine)FDA Link
03/2005
1Isotretinoin (Accutane)FDA LinkGeneric
01/2005
1Epinephrine (Adrenaline)FDA LinkGeneric
08/2004
1Dopamine (Intropin)FDA LinkGeneric
08/2004
1GhrelinIBA
08/2004
1Norepinephrine (Noradrenaline)FDA LinkGeneric
08/2004
1Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
08/2004
1Trace Elements (Biometals)IBA
06/2004
1Lipoproteins (Lipoprotein)IBA
06/2004
1ZincIBA
06/2004
1S100 Calcium Binding Protein beta SubunitIBA
01/2004
1Glucose (Dextrose)FDA LinkGeneric
11/2002
1glucose-1-phosphateIBA
11/2002

Therapy/Procedure

1Vegetarian Diet (Vegetarianism)
01/2020
1Nutritional Support (Artificial Feeding)
01/2020